Ticker LaunchIPO · LABP
Landos Biopharma, Inc.
Landos Biopharma, Inc. (LABP) priced its initial public offering on Feb 4, 2021 at $16.00 per share, within its $15.00–$17.00 range, raising $100M, and listed on Nasdaq Global Market. At the IPO price its market capitalization was about $626.6M. Latham & Watkins advised the underwriters.
- Status
- IPO
- Ticker
- LABP
- Exchange
- Nasdaq Global Market
- Priced
- Feb 4, 2021
- IPO price
- $16.00
- Price range
- $15.00–$17.00
- Raised
- $100M
- Market cap at IPO price
- $626.6M
- First filed
- Jan 13, 2021
- Underwriters' counsel
- Latham & Watkins
- Sector
- Biotech & pharma
- Country / state
- VA
Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.
More on this listing for subscribers
- Lock-up period and expiry date
- Shares offered, over-allotment and shares outstanding after the offering
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Jan 13, 2021
- Latest amendment Feb 1, 2021
- Final prospectus (424B4) Feb 4, 2021
- All filings on EDGAR CIK 1785345
Other Biotech & pharma IPOs in 2021
- Elicio Therapeutics, Inc.ANGN · Feb 5, 2021 · $80M
- Bolt Biotherapeutics, Inc.BOLT · Feb 5, 2021 · $230M
- Evaxion A/SEVAX · Feb 5, 2021
- Sana Biotechnology, Inc.SANA · Feb 5, 2021 · $587.5M
- Faeth Therapeutics, Inc.SNSE · Feb 4, 2021 · $133M
- NewcelX Ltd.NLSP · Feb 1, 2021 · $20M